Capnography Combined with Analgesia Monitoring

A new delivery module enables doctors to monitor patient-controlled analgesia (PCA) infusion along with end tidal carbon dioxide (EtCO2) and respiration rate.

The module couples the Microstream EtCO2 technology of Oridion Medical Ltd. (Jerusalem, Israel) with the medication safety system of Alaris Products (Cardinal Health, Dublin, OH, USA). With this module, a doctor has the ability to view a data trending screen that incorporates PCA infusion parameters and patient-monitoring parameters, including EtCO2 and respiration rate.

The Institute for Safe Medication Practices, a nonprofit U.S. organization, acknowledges that while PCA systems can reduce the risk of overmedication, there is still a potential for error, so hospital staff should not rely on intermittent pulse oximetry readings alone to detect toxicity. Capnography should be used on those with a heightened risk of toxicity, since it is not currently available for all patients.

"By partnering with companies like Cardinal Health, Oridion is striving to provide innovative solutions that will improve patient care by monitoring CO2 and respiration,” said Sandra Brook, clinical marketing manager, Cardinal Health, Alaris Products.





Related Links:
Oridion Medical
Cardinal Health